Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
Oxidative stress, consequences and ROS mediated cellular signaling in rheumatoid arthritis
This creates a self-reinforcing cycle: damaged cardiolipin reduces efficiency, reduced efficiency increases ROS, increased ROS damages more cardiolipin
In addition, the authors extend their gratitude to Rachel Helston (Stowers Institute for Medical Research Kansas City, MO, United States) for carrying out preliminary experiments on the endocytosis of hemeAFHPX while a post-doctoral fellow in the AS group at UMKC and to Ted White (Div